Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
38.72
-0.89 (-2.25%)
At close: Apr 24, 2024, 4:00 PM
39.04
+0.32 (0.83%)
After-hours: Apr 24, 2024, 7:35 PM EDT

BHVN Statistics

Total Valuation

BHVN has a market cap or net worth of $3.16 billion. The enterprise value is $2.81 billion.

Market Cap 3.16B
Enterprise Value 2.81B

Important Dates

The next estimated earnings date is Friday, May 10, 2024, after market close.

Earnings Date May 10, 2024
Ex-Dividend Date n/a

Share Statistics

BHVN has 81.66 million shares outstanding. The number of shares has increased by 59.14% in one year.

Shares Outstanding 81.66M
Shares Change (YoY) +59.14%
Shares Change (QoQ) +17.13%
Owned by Insiders (%) 12.74%
Owned by Institutions (%) 84.87%
Float 66.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 7.39
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.98, with a Debt / Equity ratio of 0.06.

Current Ratio 7.98
Quick Ratio n/a
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -103.50% and return on invested capital (ROIC) is -95.72%.

Return on Equity (ROE) -103.50%
Return on Assets (ROA) -80.80%
Return on Capital (ROIC) -95.72%
Revenue Per Employee n/a
Profits Per Employee -$1.71M
Employee Count 239
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -1.38M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +179.16% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +179.16%
50-Day Moving Average 51.12
200-Day Moving Average 35.13
Relative Strength Index (RSI) 27.80
Average Volume (30 Days) 1,291,438

Short Selling Information

The latest short interest is 8.57 million, so 10.49% of the outstanding shares have been sold short.

Short Interest 8.57M
Short Previous Month 7.73M
Short % of Shares Out 10.49%
Short % of Float 12.81%
Short Ratio (days to cover) 5.16

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -436.05M
Pretax Income -409.55M
Net Income -408.17M
EBITDA -402.64M
EBIT -409.55M
Earnings Per Share (EPS) -$5.73
Full Income Statement

Balance Sheet

The company has $381.82 million in cash and $27.57 million in debt, giving a net cash position of $354.25 million or $4.34 per share.

Cash & Cash Equivalents 381.82M
Total Debt 27.57M
Net Cash 354.25M
Net Cash Per Share $4.34
Equity / Book Value 427.98M
Book Value Per Share 5.24
Working Capital 387.02M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$331.73 million and capital expenditures -$3.05 million, giving a free cash flow of -$334.77 million.

Operating Cash Flow -331.73M
Capital Expenditures -3.05M
Free Cash Flow -334.77M
FCF Per Share -$4.70
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BHVN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -59.14%
Shareholder Yield -59.14%
Earnings Yield -12.91%
FCF Yield -10.59%
Dividend Details

Analyst Forecast

The average price target for BHVN is $51.63, which is 33.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target $51.63
Price Target Difference 33.34%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3